Healthcare provider profile · identity verified

Melissa Rathmell, M.D.

Family Practice · WESTBOROUGH, MA · NPI 1528025731

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	334	49
Eliquis	Apixaban	296	38
Atorvastatin Calcium	Atorvastatin Calcium	244	52
Furosemide	Furosemide	201	34
Lisinopril	Lisinopril	199	38
Gabapentin	Gabapentin	185	28
Sertraline Hcl	Sertraline Hcl	182	36
Arexvy	Rsvpref3 Antigen/As01e/Pf	163	162
Potassium Chloride	Potassium Chloride	160	28
Quetiapine Fumarate	Quetiapine Fumarate	156	22
Metoprolol Succinate	Metoprolol Succinate	155	25
Olanzapine	Olanzapine	138	18
Duloxetine Hcl	Duloxetine Hcl	137	29
Amlodipine Besylate	Amlodipine Besylate	132	29
Trazodone Hcl	Trazodone Hcl	132	29
Rosuvastatin Calcium	Rosuvastatin Calcium	127	24
Famotidine	Famotidine	114	22
Metformin Hcl	Metformin Hcl	110	19
Mirtazapine	Mirtazapine	100	20
Spironolactone	Spironolactone	91	18
Pantoprazole Sodium	Pantoprazole Sodium	85	20
Losartan Potassium	Losartan Potassium	84	20
Carvedilol	Carvedilol	82	13
Pregabalin	Pregabalin	81	18
Tamsulosin Hcl	Tamsulosin Hcl	79	16
Omeprazole	Omeprazole	71	17
Lamotrigine	Lamotrigine	65	12
Risperidone	Risperidone	62	14
Jardiance	Empagliflozin	60	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	52	suppressed
Bupropion Xl	Bupropion Hcl	48	suppressed
Diclofenac Sodium	Diclofenac Sodium	48	14
Trulicity	Dulaglutide	48	15
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	13
Clopidogrel	Clopidogrel Bisulfate	45	13
Buspirone Hcl	Buspirone Hcl	44	13
Divalproex Sodium Er	Divalproex Sodium	44	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	42	36
Fluticasone Propionate	Fluticasone Propionate	40	23
Bumetanide	Bumetanide	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Tiotropium Bromide	Tiotropium Bromide	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	19
Alendronate Sodium	Alendronate Sodium	37	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Baclofen	Baclofen	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Aripiprazole	Aripiprazole	32	suppressed
Celecoxib	Celecoxib	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Latanoprost	Latanoprost	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Meloxicam	Meloxicam	30	suppressed
Ondansetron Odt	Ondansetron	30	15
Divalproex Sodium	Divalproex Sodium	29	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	28	suppressed
Topiramate	Topiramate	27	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	suppressed
Prednisone	Prednisone	25	suppressed
Rytary	Carbidopa/Levodopa	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Methenamine Hippurate	Methenamine Hippurate	22	suppressed
Lacosamide	Lacosamide	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Vraylar	Cariprazine Hcl	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Gemtesa	Vibegron	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Ranolazine Er	Ranolazine	20	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Torsemide	Torsemide	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	17	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	16	suppressed
Desloratadine	Desloratadine	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ceftriaxone	Ceftriaxone Sodium	14	suppressed
Elmiron	Pentosan Polysulfate Sodium	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Estradiol	Estradiol	13	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Glipizide	Glipizide	12	suppressed
Methimazole	Methimazole	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Glipizide Er	Glipizide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Qulipta	Atogepant	11	suppressed
Risperidone Odt	Risperidone	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error